BSX.PRA
Morgan Stanley’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,244
| Closed | -$272K | – | 7782 |
|
|
2023
Q1 | $272K | Sell |
2,244
-26,760
| -92% | -$3.24M | ﹤0.01% | 5564 |
|
|
2022
Q4 | $3.31M | Buy |
29,004
+26,180
| +927% | +$2.99M | ﹤0.01% | 4105 |
|
|
2022
Q3 | $289K | Sell |
2,824
-2,373
| -46% | -$243K | ﹤0.01% | 5549 |
|
|
2022
Q2 | $527K | Sell |
5,197
-44,328
| -90% | -$4.5M | ﹤0.01% | 5390 |
|
|
2022
Q1 | $5.77M | Buy |
49,525
+44,085
| +810% | +$5.14M | ﹤0.01% | 3535 |
|
|
2021
Q4 | $626K | Buy |
+5,440
| New | +$626K | ﹤0.01% | 5406 |
|
|
2020
Q4 | – | Sell |
-1,906
| Closed | -$212K | – | 7166 |
|
|
2020
Q3 | $212K | Sell |
1,906
-304
| -14% | -$33.8K | ﹤0.01% | 5081 |
|
|
2020
Q2 | $230K | Buy |
+2,210
| New | +$230K | ﹤0.01% | 5012 |
|